Amarin Corp Plc (AMRN)

[Birdbrain Ideas]

Thanks for weighing in. Your knowledge of these things goes way beyond anything I know and seems to fit perfectly with KM's vague description.

A once-daily pill would surely be embraced by anyone on Vascepa, particularly those at an age where they might be taking five or six other prescription pills everyday.

He seemed quite confident that Amarin has some surprises in store for generics beyond the lawsuit.

And speaking of lawsuits, I found it fascinating that Amarin is considering suing what sounded like two of three pharmaceutical chains that list generics and Vascepa as equal or both approved for CVD reduction. I have to think the companies would just be added to the Delaware lawsuit. Including pharmaceutical chains would make it much easier to explain to a jury how the generics team up with insurance companies and pharmaceutical chains or drug stores to steer the consumer to the generic.